Handelsavisen
prelaunch
81
8190.NG Food Retail & Distribution

8190.Ng

$520,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,91 %
Op margin
-0,4 %
ROE
0,6 %
Net margin
0,1 %
Debt / equity
0,61
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.

Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
0,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 8190.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 8190.NG. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    The company's capital structure shows a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. However, the current ratio of 0.79 suggests potential liquidity constraints, as current liabilities exceed current assets. The company's liquidity position is further complicated by a negative free cash flow of -152 million JPY and a capital expenditure of -1.621 billion JPY, which may signal ongoing investment in operations.

    Profitability metrics reveal a return on equity of 0.56% and a return on assets of 0.24%, both of which are below the typical thresholds for healthy performance in the retail sector. The operating income is negative at -296 million JPY, which is a significant concern given the company's revenue of 83.24 billion JPY. This suggests that the company is struggling to convert its sales into profit, which could be a red flag for investors.

    The company's revenue is concentrated in a single business segment, as disclosed in the financial snapshot, with no specific geographic breakdown provided. This lack of diversification could pose a risk if the company's primary market experiences economic downturns or regulatory changes. The absence of detailed segment and geographic data limits the ability to assess the company's exposure to different markets.

    The company's growth trajectory is uncertain, as the operating income is negative and the free cash flow is also negative. The capital expenditure of -1.621 billion JPY indicates ongoing investment, but without a clear path to profitability, the long-term growth prospects are unclear. The company's net income of 102 million JPY is modest and does not provide a strong foundation for future expansion.

    The risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt is a concern, as it suggests the company may struggle to meet short-term obligations. The dilution risk is low, which is a positive sign for shareholders, but the company's financial health remains a concern due to the negative operating income and free cash flow.

    Recent events, as reflected in the financial data, show a last actual EPS of 5.36 JPY and a last actual revenue of 83.24 billion JPY. These figures indicate that the company is meeting analyst expectations in terms of revenue but is underperforming in terms of profitability. The negative operating income and free cash flow suggest that the company is facing operational challenges that need to be addressed.

    Key takeaways
    • The company has a moderate debt-to-equity ratio but faces liquidity constraints as indicated by a current ratio below 1.
    • Profitability is weak, with a negative operating income and low return on equity and assets.
    • The company's revenue is concentrated in a single segment, increasing exposure to market-specific risks.
    • Growth is uncertain due to negative free cash flow and capital expenditure, with no clear path to profitability.
    • Liquidity risk is medium, and dilution risk is low, but the company's financial health remains a concern.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $520,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $18.06B
    Net cash
    -$6.58B
    Current ratio
    0.8
    Debt / equity
    0.6
    ROA
    0.2%
    ROE
    0.6%
    Cash conversion
    1472.0%
    CapEx / revenue
    -1.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-0,4 %Bottom quartile
    Net Margin0,1 %Bottom quartile
    ROE0,6 %Bottom quartile
    Capex / Rev-1,9 %Above median
    D/E0,61Below median
    Cash Conv14,72Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 8190.NG Market data — financials · 2026-05-27
    • Yamanaka Co Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    8190.NGCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage